Abstract
72TiP AVALON trial: Phase IIb study of maveropepimut-s and low-dose cyclophosphamide in subjects with platinum-resistant, epithelial ovarian cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have